Jasper Therapeutics Inc. (NASDAQ: JSPR)
$21.9350
+0.0950 ( -0.07% ) 44.0K
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Market Data
Open
$21.9350
Previous close
$21.8400
Volume
44.0K
Market cap
$328.61M
Day range
$21.1660 - $23.0000
52 week range
$4.0000 - $31.0100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 09, 2024 |
8-k | 8K-related | 21 | Feb 06, 2024 |
8-k | 8K-related | 16 | Jan 04, 2024 |
8-k | 8K-related | 15 | Jan 02, 2024 |
8-k | 8K-related | 13 | Dec 20, 2023 |
4 | Insider transactions | 1 | Nov 30, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
def | Proxies and info statements | 3 | Nov 20, 2023 |
pre | Proxies and info statements | 3 | Nov 09, 2023 |